New Study reveals 95% MDR-TB treatment success and 90% pre-XDR treatment success in Belarus and Uzbekistan
A newly published study across 677 patients treated with BPaL-based regimens in non-trial settings found that successful treatment outcomes were achieved in 95.3% of patients with MDR/RR-TB and 90.4% of patients with pre-XDR-TB. The study concludes the regimens to be safe and highly effective, and suggests they should be considered for widespread implementation globally.